-
Merck shares target cut, market perform rating on Gardasil China woes By Investing.com
Source: Buzz FX / 02 Dec 2024 07:32:15 America/Chicago
On Monday, Bernstein SocGen Group adjusted its outlook on shares of Merck (NS: PROR ) & Co., Inc. (NYSE:MRK), reducing the pharmaceutical giant's price target from $115.00 to $110.00, but maintaining a Market Perform rating on the stock.
Read more...